Â© 2000-2024 QIAGEN. All rights reserved.

Ingenuity Canonical Pathways	 -log(p-value)	Ratio	z-score	Molecules	
Eukaryotic Translation Termination	5.35E01	4.47E-01	6.481	FAU,RPL10,RPL11,RPL15,RPL17,RPL22,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
Eukaryotic Translation Elongation	5.32E01	4.42E-01	6.481	FAU,RPL10,RPL11,RPL15,RPL17,RPL22,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
Response of EIF2AK4 (GCN2) to amino acid deficiency	5.31E01	4.17E-01	6.557	EIF2AK4,FAU,RPL10,RPL11,RPL15,RPL17,RPL22,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
SRP-dependent cotranslational protein targeting to membrane	5.06E01	3.74E-01	6.557	FAU,RPL10,RPL11,RPL15,RPL17,RPL22,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8,SEC61G	
Selenoamino acid metabolism	5.05E01	3.93E-01	6.481	FAU,RPL10,RPL11,RPL15,RPL17,RPL22,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
Eukaryotic Translation Initiation	4.93E01	3.52E-01	6.557	EIF4EBP1,FAU,RPL10,RPL11,RPL15,RPL17,RPL22,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
Nonsense-Mediated Decay (NMD)	4.85E01	3.59E-01	6.481	FAU,RPL10,RPL11,RPL15,RPL17,RPL22,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
EIF2 Signaling	4.28E01	2.09E-01	5.000	EIF2AK4,FAU,RASD1,RPL10,RPL11,RPL15,RPL17,RPL22,Rpl22l1,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,Rpl34 (includes others),RPL35,RPL35A,Rpl36,Rpl36a,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
Major pathway of rRNA processing in the nucleolus and cytosol	4.03E01	2.31E-01	6.557	FAU,RPL10,RPL11,RPL15,RPL17,RPL22,RPL23,RPL26,RPL27,RPL27A,RPL28,RPL30,RPL31,RPL35,RPL35A,RPL37,RPL37A,RPL38,RPL39,RPL41,RPL9,RPLP2,RPP21,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
mTOR Signaling	1.81E01	1.26E-01	2.000	DDIT4,EIF4EBP1,FAU,PPP2R2D,RASD1,RHOB,RHOC,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
Regulation of eIF4 and p70S6K Signaling	1.65E01	1.3E-01	NaN	EIF4EBP1,FAU,PPP2R2D,RASD1,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8	
Coronavirus Pathogenesis Pathway	1.44E01	1.13E-01	-4.379	FAU,NFKBIA,RPS10,RPS12,RPS13,RPS15,RPS15A,RPS16,RPS17,RPS18,RPS19,RPS20,RPS21,RPS23,RPS24,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS6,RPS8,STAT1	
Oxidative Phosphorylation	1.41E01	1.61E-01	4.243	COX17,COX6A1,COX6B1,Cox6c,COX7A2,COX8A,NDUFA1,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFB3,NDUFB4,UQCR10,UQCR11,UQCRB	
Electron transport, ATP synthesis, and heat production by uncoupling proteins	1.31E01	1.41E-01	4.243	COX6A1,COX6B1,COX8A,NDUFA1,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFB3,NDUFB4,NDUFC1,NDUFC2,UCP2,UQCR10,UQCR11,UQCRB	
Granzyme A Signaling	8.46E00	1.49E-01	-3.317	HMGB2,NDUFA1,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFB3,NDUFB4,Serpinb6b	
Mitochondrial Dysfunction	7.44E00	5.81E-02	-4.472	COX17,COX6A1,COX6B1,Cox6c,COX7A2,COX8A,NDUFA1,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFB3,NDUFB4,TOMM7,UCP2,UQCR10,UQCR11,UQCRB	
Sirtuin Signaling Pathway	6.44E00	5.84E-02	-2.324	DUSP6,GABARAPL2,HMGCS2,NDRG1,NDUFA1,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFB3,NDUFB4,SLC2A1,TOMM6,TOMM7,UCP2	
RHO GTPases activate CIT	5.42E00	2.63E-01	2.236	CDKN1B,MYL12B,MYL6,RHOB,RHOC	
IL-8 Signaling	4.62E00	5.71E-02	3.162	BCL2L1,CCND3,CSTB,EIF4EBP1,GNG11,GNG5,IRAK2,MYL12B,NFKBIA,RASD1,RHOB,RHOC	
Interferon alpha/beta signaling	4.38E00	9.86E-02	2.646	EGR1,IFI35,IFIT3,IFITM2,RSAD2,STAT1,XAF1	
RHO GTPases Activate ROCKs	4.01E00	2.11E-01	2.000	MYL12B,MYL6,RHOB,RHOC	
Glucocorticoid Receptor Signaling	4E00	3.44E-02	NaN	BCL2L1,CDKN1A,DUSP1,FKBP5,GJA1,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFB3,NDUFB4,NFKBIA,POLR2K,POLR2L,RASD1,SGK1,STAT1,TSC22D3	
Semaphorin interactions	3.71E00	9.38E-02	2.449	MYL12B,MYL6,PLXNA2,RHOB,RHOC,SEMA7A	
MAPK6/MAPK4 signaling	3.67E00	7.61E-02	NaN	CCND3,CDC42EP3,HSPB1,PSMA6,PSME1,RPS27A,SEM1	
HER-2 Signaling in Breast Cancer	3.65E00	4.85E-02	-1.508	CDKN1A,CDKN1B,COX17,COX6A1,COX6B1,Cox6c,COX7A2,COX8A,NFKBIA,RASD1,RPS6	
Estrogen Receptor Signaling	3.43E00	3.67E-02	1.134	CDKN1A,EIF4EBP1,GNG11,GNG5,MYL12B,MYL6,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFB3,NDUFB4,RASD1	
Huntington's Disease Signaling	3.38E00	4.23E-02	1.890	BCL2L1,GNG11,GNG5,POLR2K,POLR2L,PSMA6,PSME1,RPS27A,SEM1,SGK1,Ubb,UBE2S	
TP53 Regulates Transcription of Cell Cycle Genes	3.34E00	1.02E-01	2.236	BTG2,CDKN1A,CDKN1B,PLK2,RGCC	
RHO GTPases activate PKNs	3.33E00	1.43E-01	2.000	MYL12B,MYL6,RHOB,RHOC	
G alpha (12/13) signalling events	3.18E00	7.5E-02	2.449	GNG11,GNG5,MCF2L,NET1,RHOB,RHOC	
PEDF Signaling	3.07E00	7.14E-02	1.000	BCL2L1,FAS,NFKBIA,PNPLA2,RASD1,WASF2	
Regulation of mitotic cell cycle	2.96E00	6.82E-02	2.449	PSMA6,PSME1,PTTG1,RPS27A,SEM1,UBE2S	
TP53 Regulates Metabolic Genes	2.96E00	6.82E-02	2.449	COX6A1,COX6B1,COX8A,DDIT4,NDUFA4,SESN1	
Interferon Signaling	2.91E00	1.11E-01	2.000	IFI35,IFIT3,IFITM2,STAT1	
KEAP1-NFE2L2 pathway	2.89E00	6.59E-02	2.449	CDKN1A,PSMA6,PSME1,RPS27A,SEM1,SESN1	
Cytoprotection by HMOX1	2.87E00	8.06E-02	2.236	COX6A1,COX6B1,COX8A,NDUFA4,TXNIP	
Transcriptional regulation by RUNX3	2.77E00	6.25E-02	2.449	CCN2,CDKN1A,PSMA6,PSME1,RPS27A,SEM1	
Mitotic G1 phase and G1/S transition	2.75E00	5.34E-02	2.449	CCND3,CDKN1A,CDKN1B,PSMA6,PSME1,RPS27A,SEM1	
CXCR4 Signaling	2.75E00	4.76E-02	2.646	EGR1,GNG11,GNG5,MYL12B,MYL6,RASD1,RHOB,RHOC	
TNFR2 non-canonical NF-kB pathway	2.69E00	7.35E-02	2.236	PSMA6,PSME1,RPS27A,SEM1,TNFRSF12A	
S Phase	2.68E00	6E-02	2.449	CDKN1A,CDKN1B,PSMA6,PSME1,RPS27A,SEM1	
Regulation of RUNX2 expression and activity	2.56E00	6.85E-02	2.236	PSMA6,PSME1,RPS27A,SEM1,STAT1	
Hereditary Breast Cancer Signaling	2.55E00	4.93E-02	NaN	CCND3,CDKN1A,POLR2K,POLR2L,RASD1,RPS27A,Ubb	
Signaling by Rho Family GTPases	2.53E00	3.75E-02	1.890	CDC42EP3,CDC42EP4,CLIP1,GNG11,GNG5,MYL12B,MYL6,RHOB,RHOC,STMN1	
Antiproliferative Role of Somatostatin Receptor 2	2.46E00	6.49E-02	0.000	CDKN1A,CDKN1B,GNG11,GNG5,RASD1	
Mitotic Metaphase and Anaphase	2.39E00	3.83E-02	3.000	CHMP4B,CLIP1,PSMA6,PSME1,PTTG1,RPS27A,SEM1,TUBB2A,UBE2S	
Signaling by NOTCH4	2.32E00	6.02E-02	2.236	DLL4,PSMA6,PSME1,RPS27A,SEM1	
Synthesis of DNA	2.3E00	5.04E-02	2.449	POLE4,PSMA6,PSME1,RPS27A,SEM1,UBE2S	
Regulation of Apoptosis	2.28E00	7.55E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
ID1 Signaling Pathway	2.28E00	3.98E-02	1.414	BCL2L1,CCN2,CDKN1A,CDKN1B,EGR1,RASD1,RHOC,SMAD1	
RHO GTPases Activate Rhotekin and Rhophilins	2.23E00	2.22E-01	NaN	RHOB,RHOC	
NLR signaling pathways	2.2E00	7.14E-02	2.000	BCL2L1,IRAK2,RPS27A,TXNIP	
RHO GTPase cycle	2.15E00	2.89E-02	3.606	AKAP12,CDC42EP3,CDC42EP4,CYBA,GJA1,HSPE1,MCF2L,NDUFA5,NET1,RALBP1,RHOB,RHOC,WASF2	
Mitophagy	2.15E00	1E-01	NaN	RPS27A,TOMM6,TOMM7	
Neutrophil Extracellular Trap Signaling Pathway	2.15E00	3E-02	3.464	NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFB3,NDUFB4,PNPLA2,SLC2A1,TOMM6,TOMM7	
Ketone body metabolism	2.14E00	2E-01	NaN	HMGCL,HMGCS2	
Interleukin-1 family signaling	2.14E00	4.65E-02	2.449	IRAK2,NFKBIA,PSMA6,PSME1,RPS27A,SEM1	
Glioblastoma Multiforme Signaling	2.12E00	4.09E-02	0.447	CCND3,CDKN1A,CDKN1B,FZD4,RASD1,RHOB,RHOC	
Cardiac Hypertrophy Signaling	2.1E00	3.45E-02	2.828	GNG11,GNG5,HSPB1,MAP3K6,MYL12B,MYL6,RASD1,RHOB,RHOC	
NIK-->noncanonical NF-kB signaling	2.09E00	6.67E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
Semaphorin Signaling in Neurons	2.07E00	6.56E-02	NaN	PLXNA2,RHOB,RHOC,SEMA7A	
Ketogenesis	2.06E00	1.82E-01	NaN	HMGCL,HMGCS2	
Salvage Pathways of Pyrimidine Ribonucleotides	2.04E00	5.15E-02	2.236	CMPK2,DAPK1,HIPK1,MAP3K6,SGK1	
Mitochondrial protein import	2E00	6.25E-02	2.000	CHCHD2,COX17,TOMM6,TOMM7	
Hedgehog ligand biogenesis	1.97E00	6.15E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
Pyridoxal 5'-phosphate Salvage Pathway	1.97E00	6.15E-02	2.000	DAPK1,HIPK1,MAP3K6,SGK1	
CGAS-STING Signaling Pathway	1.97E00	4.29E-02	1.633	ATP6V1G1,CDKN1A,GJA1,LRRC8A,NFKBIA,STAT1	
DNA Replication Pre-Initiation	1.91E00	4.81E-02	2.236	PSMA6,PSME1,RPS27A,SEM1,UBE2S	
Cell Cycle: G1/S Checkpoint Regulation	1.89E00	5.8E-02	1.000	CCND3,CDKN1A,CDKN1B,RPL11	
PTEN Regulation	1.83E00	4E-02	2.449	EGR1,MKRN1,PSMA6,PSME1,RPS27A,SEM1	
Interleukin-4 and Interleukin-13 signaling	1.82E00	4.55E-02	2.236	BCL2L1,CDKN1A,CEBPD,S1PR1,STAT1	
Senescence-Associated Secretory Phenotype (SASP)	1.8E00	5.48E-02	2.000	CDKN1A,CDKN1B,RPS27A,UBE2S	
Extra-nuclear estrogen signaling	1.8E00	5.48E-02	2.000	CDKN1B,GNG11,GNG5,HSPB1	
Glioma Invasiveness Signaling	1.8E00	5.48E-02	NaN	RASD1,RHOB,RHOC,TIMP3	
YAP1- and WWTR1 (TAZ)-stimulated gene expression	1.79E00	1.33E-01	NaN	CCN2,HIPK1	
IL-10 Signaling	1.78E00	3.9E-02	1.633	BCL2L1,CDKN1A,DDIT4,DUSP1,NFKBIA,STAT1	
Hedgehog 'off' state	1.77E00	4.42E-02	NaN	PSMA6,PSME1,RPS27A,SEM1,TUBB2A	
PI3K/AKT Signaling	1.77E00	3.5E-02	1.000	BCL2L1,CDKN1A,CDKN1B,EIF4EBP1,NFKBIA,PPP2R2D,RASD1	
Cellular response to hypoxia	1.76E00	5.33E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
Smooth Muscle Contraction	1.72E00	6.98E-02	NaN	MYL12B,MYL6,SORBS3	
Oncostatin M Signaling	1.72E00	6.98E-02	NaN	RASD1,STAT1,TIMP3	
Toll-like Receptor Signaling	1.71E00	5.13E-02	NaN	IRAK2,NFKBIA,RPS27A,Ubb	
IL-7 Signaling Pathway	1.71E00	5.13E-02	1.000	CCND3,CDKN1B,SLC2A1,STAT1	
TAK1-dependent IKK and NF-kappa-B activation	1.7E00	6.82E-02	NaN	IRAK2,NFKBIA,RPS27A	
Regulation of mRNA stability by proteins that bind AU-rich elements	1.7E00	6.82E-02	NaN	HSPB1,RPS27A,ZFP36	
TP53 Regulates Transcription of Cell Death Genes	1.7E00	6.82E-02	NaN	FAS,NDRG1,TP53INP1	
Renal Cell Carcinoma Signaling	1.69E00	5.06E-02	NaN	RASD1,RPS27A,SLC2A1,Ubb	
FOXO-mediated transcription of cell cycle genes	1.69E00	1.18E-01	NaN	CDKN1A,CDKN1B	
p38 MAPK Signaling	1.67E00	4.17E-02	1.342	DUSP1,FAS,HSPB1,IRAK2,STAT1	
DNA damage-induced 14-3-3Ï Signaling	1.65E00	6.52E-02	NaN	BCL2L1,CDKN1A,CDKN1B	
JAK/STAT Signaling	1.64E00	4.88E-02	NaN	BCL2L1,CDKN1A,RASD1,STAT1	
iNOS Signaling	1.62E00	6.38E-02	NaN	IRAK2,NFKBIA,STAT1	
Hepatic Fibrosis Signaling Pathway	1.6E00	2.6E-02	1.897	CCN2,CDKN1B,FZD4,IRAK2,KLF9,MYL12B,MYL6,NFKBIA,RASD1,RHOB,RHOC	
TCR signaling	1.59E00	3.97E-02	2.236	NFKBIA,PSMA6,PSME1,RPS27A,SEM1	
Pancreatic Adenocarcinoma Signaling	1.59E00	3.97E-02	2.000	BCL2L1,CDKN1A,CDKN1B,RALBP1,STAT1	
BAG2 Signaling Pathway	1.59E00	4.71E-02	NaN	CDKN1A,PSMA6,PSME1,SEM1	
Hedgehog 'on' state	1.57E00	4.65E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	1.57E00	4.65E-02	1.000	IFIT3,RSAD2,S1PR1,STAT1	
Cyclins and Cell Cycle Regulation	1.57E00	4.65E-02	NaN	CCND3,CDKN1A,CDKN1B,PPP2R2D	
RHOGDI Signaling	1.57E00	3.18E-02	-2.236	GNG11,GNG5,MYL12B,MYL6,RHOB,RHOC,WASF2	
Colorectal Cancer Metastasis Signaling	1.56E00	2.95E-02	2.646	BCL2L1,FZD4,GNG11,GNG5,RASD1,RHOB,RHOC,STAT1	
Signaling by NOTCH3	1.55E00	6E-02	NaN	DLL4,RPS27A,STAT1	
Cell Cycle Checkpoints	1.55E00	2.94E-02	2.828	CDKN1A,CDKN1B,CLIP1,PSMA6,PSME1,RPS27A,SEM1,UBE2S	
Protein Ubiquitination Pathway	1.54E00	2.93E-02	NaN	HSPB1,HSPE1,PSMA6,PSME1,RPS27A,Ubb,UBE2S,USP54	
Ferroptosis Signaling Pathway	1.53E00	3.82E-02	-0.447	ANGPTL4,CDKN1A,GCH1,HSPB1,RASD1	
Thrombin Signaling	1.52E00	3.11E-02	NaN	GNG11,GNG5,MYL12B,MYL6,RASD1,RHOB,RHOC	
RHO GTPases activate PAKs	1.51E00	9.52E-02	NaN	MYL12B,MYL6	
Degradation of beta-catenin by the destruction complex	1.48E00	4.35E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
Amino acids regulate mTORC1	1.45E00	5.45E-02	NaN	ATP6V1G1,CASTOR1,SESN1	
RAF-independent MAPK1/3 activation	1.44E00	8.7E-02	NaN	DUSP1,DUSP6	
Vitamin-C Transport	1.44E00	8.7E-02	NaN	LRRC8A,SLC2A1	
Adipogenesis pathway	1.43E00	3.6E-02	-0.447	CEBPD,FZD4,SAP18,SMAD1,TXNIP	
Small Cell Lung Cancer Signaling	1.42E00	4.17E-02	NaN	BCL2L1,CCND3,CDKN1B,NFKBIA	
IL-1 Signaling	1.42E00	4.17E-02	NaN	GNG11,GNG5,IRAK2,NFKBIA	
Death Receptor Signaling	1.42E00	4.17E-02	0.000	FAS,HSPB1,NFKBIA,TIPARP	
Lactose synthesis	1.41E00	3.33E-01	NaN	SLC2A1	
Tetrahydrobiopterin Biosynthesis I	1.41E00	3.33E-01	NaN	GCH1	
Biotin-carboxyl Carrier Protein Assembly	1.41E00	3.33E-01	NaN	ACACB	
Tetrahydrobiopterin Biosynthesis II	1.41E00	3.33E-01	NaN	GCH1	
CD27 Signaling in Lymphocytes	1.41E00	5.26E-02	NaN	BCL2L1,MAP3K6,NFKBIA	
FAT10 Signaling Pathway	1.41E00	5.26E-02	NaN	PSMA6,PSME1,SEM1	
Nucleotide Excision Repair	1.41E00	4.12E-02	2.000	POLE4,POLR2K,POLR2L,RPS27A	
RAS processing	1.4E00	8.33E-02	NaN	BCL2L1,RPS27A	
p53 Signaling	1.39E00	4.08E-02	1.000	BCL2L1,CDKN1A,FAS,TP53INP1	
UVA-Induced MAPK Signaling	1.39E00	4.08E-02	NaN	BCL2L1,RASD1,STAT1,TIPARP	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	1.39E00	3.14E-02	2.449	CYBA,MAP3K6,NFKBIA,RHOB,RHOC,STAT1	
AMPK Signaling	1.38E00	2.89E-02	NaN	ACACB,CDKN1A,EIF4EBP1,GNG11,GNG5,PPP2R2D,SLC2A1	
MyD88 cascade initiated on plasma membrane	1.37E00	8E-02	NaN	IRAK2,RPS27A	
Signaling by ERBB4	1.37E00	5.08E-02	NaN	MXD4,RPS27A,STMN1	
Metabolism of polyamines	1.37E00	5.08E-02	NaN	PSMA6,PSME1,SEM1	
C-type lectin receptors (CLRs)	1.37E00	3.45E-02	2.000	NFKBIA,PSMA6,PSME1,RPS27A,SEM1	
p75 NTR receptor-mediated signalling	1.36E00	4E-02	2.000	MCF2L,NET1,NFKBIA,RPS27A	
ABC-family proteins mediated transport	1.35E00	3.96E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
Estrogen-mediated S-phase Entry	1.34E00	7.69E-02	NaN	CDKN1A,CDKN1B	
Beta-catenin independent WNT signaling	1.34E00	3.92E-02	2.000	FZD4,GNG11,GNG5,RPS27A	
Integration of energy metabolism	1.33E00	3.88E-02	NaN	ADIPOR2,GNG11,GNG5,SLC2A1	
Mitotic Prophase	1.33E00	3.88E-02	2.000	ARPP19,LPIN2,NEK7,PPP2R2D	
Sumoylation Pathway	1.33E00	3.88E-02	NaN	FAS,NFKBIA,RHOB,RHOC	
Role of JAK2 in Hormone-like Cytokine Signaling	1.32E00	4.84E-02	NaN	BCL2L1,CCND3,STAT1	
Mitotic G2-G2/M phases	1.31E00	3.02E-02	2.449	CDKN1A,PSMA6,PSME1,RPS27A,SEM1,TUBB2A	
Apoptosis Signaling	1.31E00	3.85E-02	NaN	BCL2L1,FAS,NFKBIA,RASD1	
NAD Signaling Pathway	1.3E00	3.31E-02	NaN	GJA1,HMGCS2,POLR2K,POLR2L,TIPARP	
MTOR signalling	1.28E00	7.14E-02	NaN	EIF4EBP1,RPS6	
Induction of Apoptosis by HIV1	1.27E00	4.62E-02	NaN	BCL2L1,FAS,NFKBIA	
Necroptosis Signaling Pathway	1.26E00	3.23E-02	2.236	DAPK1,FAS,STAT1,TOMM6,TOMM7	
mRNA Capping	1.26E00	6.9E-02	NaN	POLR2K,POLR2L	
Fc epsilon receptor (FCERI) signaling	1.26E00	2.91E-02	2.236	NFKBIA,PSMA6,PSME1,RASGRP2,RPS27A,SEM1	
Mitotic Roles of Polo-Like Kinase	1.23E00	4.48E-02	NaN	PLK2,PPP2R2D,PTTG1	
RAR Activation	1.23E00	2.33E-02	1.897	CDKN1A,CDKN1B,DUSP1,KLF2,PDE2A,RHOB,RHOC,SORBS3,STRA6,ZBTB16	
Activation of kainate receptors upon glutamate binding	1.23E00	6.67E-02	NaN	GNG11,GNG5	
Protein ubiquitination	1.23E00	6.67E-02	NaN	RPS27A,UBE2S	
Signaling by CSF3 (G-CSF)	1.23E00	6.67E-02	NaN	RPS27A,STAT1	
RAF/MAP kinase cascade	1.23E00	2.67E-02	2.646	DUSP1,DUSP6,PSMA6,PSME1,RANBP9,RPS27A,SEM1	
Aryl Hydrocarbon Receptor Signaling	1.23E00	3.14E-02	-1.000	CCND3,CDKN1A,CDKN1B,FAS,HSPB1	
RHO GTPases activate IQGAPs	1.2E00	6.45E-02	NaN	CLIP1,TUBB2A	
Endosomal Sorting Complex Required For Transport (ESCRT)	1.2E00	6.45E-02	NaN	CHMP4B,RPS27A	
Signaling by CSF1 (M-CSF) in myeloid cells	1.2E00	6.45E-02	NaN	RPS27A,STAT1	
MyD88 dependent cascade initiated on endosome	1.2E00	6.45E-02	NaN	IRAK2,RPS27A	
SPINK1 General Cancer Pathway	1.2E00	4.35E-02	NaN	Mt1,Mt2,RASD1	
Prostate Cancer Signaling	1.19E00	3.51E-02	NaN	CDKN1A,CDKN1B,NFKBIA,RASD1	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	1.19E00	3.51E-02	NaN	ATP6V1G1,NFKBIA,PNPLA2,RASD1	
FasL/ CD95L signaling	1.19E00	2E-01	NaN	FAS	
Inhibition of ARE-Mediated mRNA Degradation Pathway	1.19E00	3.07E-02	NaN	PPP2R2D,PSMA6,PSME1,SEM1,ZFP36	
TP53 Regulates Transcription of DNA Repair Genes	1.19E00	4.29E-02	NaN	POLR2K,POLR2L,SUPT4H1	
GM-CSF Signaling	1.19E00	4.29E-02	NaN	BCL2L1,RASD1,STAT1	
ERK/MAPK Signaling	1.18E00	2.79E-02	-0.447	DUSP1,DUSP6,EIF4EBP1,HSPB1,RASD1,STAT1	
Regulation of Actin-based Motility by Rho	1.18E00	3.48E-02	2.000	MYL12B,MYL6,RHOB,RHOC	
G-protein beta:gamma signalling	1.18E00	6.25E-02	NaN	GNG11,GNG5	
Thrombin signalling through proteinase activated receptors (PARs)	1.18E00	6.25E-02	NaN	GNG11,GNG5	
RIPK1-mediated regulated necrosis	1.18E00	6.25E-02	NaN	FAS,RPS27A	
Signaling by ROBO receptors	1.17E00	3.45E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
Autophagy	1.17E00	2.76E-02	2.236	BNIP3,CDKN1B,DAPK1,GABARAPL2,PPP2R2D,SESN1	
Activin Inhibin Signaling Pathway	1.16E00	2.75E-02	0.816	CCN2,CDKN1A,CDKN1B,NFKBIA,PNPLA2,SMAD1	
Signal amplification	1.16E00	6.06E-02	NaN	GNG11,GNG5	
Signaling by FGFR2	1.14E00	4.11E-02	NaN	POLR2K,POLR2L,RPS27A	
Gap junction trafficking and regulation	1.13E00	5.88E-02	NaN	GJA1,TUBB2A	
Signaling by NOTCH2	1.13E00	5.88E-02	NaN	DLL4,RPS27A	
Late endosomal microautophagy	1.13E00	5.88E-02	NaN	CHMP4B,RPS27A	
Sphingosine-1-phosphate Signaling	1.13E00	3.33E-02	NaN	ACER2,RHOB,RHOC,S1PR1	
Signaling by the B Cell Receptor (BCR)	1.13E00	2.94E-02	2.236	NFKBIA,PSMA6,PSME1,RPS27A,SEM1	
Germ Cell-Sertoli Cell Junction Signaling	1.13E00	2.94E-02	NaN	MAP3K6,RASD1,RHOB,RHOC,TUBB2A	
GÎ±q Signaling	1.13E00	2.94E-02	2.000	GNG11,GNG5,NFKBIA,RHOB,RHOC	
Chronic Myeloid Leukemia Signaling	1.12E00	2.52E-02	0.378	BCL2L1,CCND3,CDKN1A,CDKN1B,FAS,FZD4,RASD1	
Lipid particle organization	1.12E00	1.67E-01	NaN	HILPDA	
Nucleotide Excision Repair Pathway	1.11E00	5.71E-02	NaN	POLR2K,POLR2L	
Oxytocin Signaling Pathway	1.1E00	2.48E-02	2.646	GJA1,GNG11,GNG5,HSPB1,MYL6,PNPLA2,RASD1	
WNT/Î²-catenin Signaling	1.09E00	2.87E-02	NaN	FZD4,GJA1,PPP2R2D,RPS27A,Ubb	
FLT3 Signaling	1.09E00	5.56E-02	NaN	CDKN1B,RPS27A	
RHOA Signaling	1.09E00	3.23E-02	2.000	CDC42EP3,CDC42EP4,MYL12B,MYL6	
G-Protein Coupled Receptor Signaling	1.08E00	1.99E-02	2.138	ACKR3,ADGRG1,DUSP1,DUSP6,FZD4,GNG11,GNG5,MAP3K6,MYL12B,MYL6,NFKBIA,PDE2A,RASD1,S1PR1	
MyD88-independent TLR4 cascade	1.07E00	5.41E-02	NaN	IRAK2,RPS27A	
Detoxification of Reactive Oxygen Species	1.07E00	5.41E-02	NaN	ATOX1,CYBA	
TWEAK Signaling	1.07E00	5.41E-02	NaN	NFKBIA,TNFRSF12A	
Role of JAK family kinases in IL-6-type Cytokine Signaling	1.06E00	3.8E-02	NaN	BCL2L1,CEBPD,STAT1	
Endocannabinoid Developing Neuron Pathway	1.06E00	3.15E-02	NaN	CDKN1B,GNG11,GNG5,RASD1	
Phosphatidylcholine Biosynthesis I	1.05E00	1.43E-01	NaN	CHKA	
Ceramide Degradation	1.05E00	1.43E-01	NaN	ACER2	
TR/RXR Activation	1.05E00	3.12E-02	2.000	ENO1,KLF9,SLC2A1,UCP2	
Cell Cycle Regulation by BTG Family Proteins	1.05E00	5.26E-02	NaN	BTG2,PPP2R2D	
Cardiac Î²-adrenergic Signaling	1.05E00	2.78E-02	NaN	AKAP12,GNG11,GNG5,PDE2A,PPP2R2D	
MAP kinase activation	1.03E00	5.13E-02	NaN	IRAK2,RPS27A	
Regulation of TP53 Expression and Degradation	1.03E00	5.13E-02	NaN	RPS27A,SGK1	
NGF-stimulated transcription	1.03E00	5.13E-02	NaN	EGR1,SGK1	
FLT3 Signaling in Hematopoietic Progenitor Cells	1.03E00	3.66E-02	NaN	EIF4EBP1,RASD1,STAT1	
BEX2 Signaling Pathway	1.03E00	3.66E-02	NaN	CDKN1A,NFKBIA,PPP2R2D	
Protein Kinase A Signaling	1.02E00	2.19E-02	0.000	AKAP12,DUSP1,DUSP6,GNG11,GNG5,MYL12B,MYL6,NFKBIA,PDE2A	
fMLP Signaling in Neutrophils	1.02E00	3.05E-02	NaN	GNG11,GNG5,NFKBIA,RASD1	
RNA polymerase II transcribes snRNA genes	1.02E00	3.61E-02	NaN	POLR2K,POLR2L,SUPT4H1	
GABA Receptor Signaling	1.01E00	3.03E-02	NaN	GNG11,GNG5,RPS27A,Ubb	
GÎ±12/13 Signaling	1E00	3.01E-02	NaN	MYL12B,MYL6,NFKBIA,RASD1	
Transcriptional regulation of white adipocyte differentiation	1E00	3.57E-02	NaN	ANGPTL4,CCND3,CEBPD	
Serine biosynthesis	9.98E-01	1.25E-01	NaN	SERINC3	
Senescence Pathway	9.95E-01	2.34E-02	1.342	CCND3,CDKN1A,CDKN1B,EIF4EBP1,PPP2R2D,RASD1,SMAD1	
RNA Polymerase III Transcription	9.94E-01	4.88E-02	NaN	POLR2K,POLR2L	
Molecular Mechanisms of Cancer	9.92E-01	1.87E-02	3.000	ACKR3,ADGRG1,BCL2L1,CCND3,CDKN1A,FAS,FZD4,GNG11,GNG5,NFKBIA,RALBP1,RASD1,RHOB,RHOC,S1PR1,SMAD1	
Platelet homeostasis	9.81E-01	3.49E-02	NaN	GNG11,GNG5,PDE2A	
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	9.77E-01	4.76E-02	NaN	IRAK2,RPS27A	
Macrophage Alternative Activation Signaling Pathway	9.72E-01	2.63E-02	1.342	DUSP1,EIF4EBP1,NFKBIA,STAT1,TSC22D3	
Neddylation	9.7E-01	2.44E-02	2.449	CDKN1A,PSMA6,PSME1,RPS27A,SEM1,ZBTB16	
GNRH Signaling	9.65E-01	2.62E-02	2.000	EGR1,GNG11,GNG5,MAP3K6,RASD1	
Vasopressin regulates renal water homeostasis via Aquaporins	9.6E-01	4.65E-02	NaN	GNG11,GNG5	
Aggrephagy	9.6E-01	4.65E-02	NaN	RPS27A,TUBB2A	
RHO GTPases Activate Formins	9.52E-01	2.88E-02	2.000	CLIP1,RHOB,RHOC,TUBB2A	
Butyrophilin (BTN) family interactions	9.49E-01	1.11E-01	NaN	XDH	
Interleukin-9 signaling	9.49E-01	1.11E-01	NaN	STAT1	
Sphingosine and Sphingosine-1-phosphate Metabolism	9.49E-01	1.11E-01	NaN	ACER2	
Phosphatidylethanolamine Biosynthesis II	9.49E-01	1.11E-01	NaN	CHKA	
Leucine Degradation I	9.49E-01	1.11E-01	NaN	HMGCL	
GÎ±i Signaling	9.44E-01	2.86E-02	NaN	GNG11,GNG5,RASD1,S1PR1	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	9.44E-01	2.58E-02	NaN	CCN2,FAS,KLF6,MYL6,STAT1	
Cachexia Signaling Pathway	9.42E-01	2.17E-02	2.828	CEBPD,DDIT4,PNPLA2,PSMA6,PSME1,S1PR1,STAT1,TNFRSF12A	
Regulation of Cellular Mechanics by Calpain Protease	9.37E-01	3.33E-02	NaN	CCND3,CDKN1B,RASD1	
Apelin Endothelial Signaling Pathway	9.36E-01	2.84E-02	NaN	GNG11,GNG5,KLF2,RASD1	
Carboxyterminal post-translational modifications of tubulin	9.27E-01	4.44E-02	NaN	TTLL7,TUBB2A	
GPER1 signaling	9.27E-01	4.44E-02	NaN	GNG11,GNG5	
Coronavirus Replication Pathway	9.27E-01	4.44E-02	NaN	IFITM2,TUBB2A	
Ceramide Signaling	9.26E-01	3.3E-02	NaN	PPP2R2D,RASD1,S1PR1	
NER (Nucleotide Excision Repair, Enhanced Pathway)	9.26E-01	3.3E-02	NaN	POLE4,POLR2K,POLR2L	
ABRA Signaling Pathway	9.16E-01	3.26E-02	NaN	CCN2,EGR1,Tpm4	
Cytosolic sensors of pathogen-associated DNA	9.11E-01	4.35E-02	NaN	NFKBIA,RPS27A	
Pulmonary Healing Signaling Pathway	9.1E-01	2.51E-02	2.236	ACKR3,FZD4,NFKBIA,RASD1,SMAD1	
TCF dependent signaling in response to WNT	9.1E-01	2.51E-02	2.236	FZD4,PSMA6,PSME1,RPS27A,SEM1	
Class I MHC mediated antigen processing and presentation	9.08E-01	2.13E-02	2.828	CYBA,MKRN1,PSMA6,PSME1,RPS27A,SEM1,UBE2S,ZBTB16	
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	9.06E-01	1E-01	NaN	TSC22D1	
Caspase activation via Dependence Receptors in the absence of ligand	9.06E-01	1E-01	NaN	DAPK1	
Regulation of TP53 Activity through Phosphorylation	9.06E-01	3.23E-02	NaN	HIPK1,RPS27A,TP53INP1	
Actin Nucleation by ARP-WASP Complex	9.06E-01	3.23E-02	NaN	RASD1,RHOB,RHOC	
G alpha (z) signalling events	8.81E-01	4.17E-02	NaN	GNG11,GNG5	
DNA Damage Bypass	8.81E-01	4.17E-02	NaN	POLE4,RPS27A	
Apelin Muscle Signaling Pathway	8.81E-01	4.17E-02	NaN	GNG11,GNG5	
Class B/2 (Secretin family receptors)	8.76E-01	3.12E-02	NaN	FZD4,GNG11,GNG5	
RNA Polymerase II Transcription	8.73E-01	2.68E-02	2.000	POLR2K,POLR2L,SNRPF,SUPT4H1	
Deubiquitination	8.7E-01	2.28E-02	2.449	NFKBIA,PSMA6,PSME1,RPS27A,SEM1,SMAD1	
SUMOylation of immune response proteins	8.68E-01	9.09E-02	NaN	NFKBIA	
Alpha-protein kinase 1 signaling pathway	8.68E-01	9.09E-02	NaN	RPS27A	
Pexophagy	8.68E-01	9.09E-02	NaN	RPS27A	
Dolichyl-diphosphooligosaccharide Biosynthesis	8.68E-01	9.09E-02	NaN	DPM3	
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	8.67E-01	4.08E-02	NaN	RPS27A,STAT1	
Semaphorin Neuronal Repulsive Signaling Pathway	8.65E-01	2.67E-02	2.000	MYL12B,MYL6,PLXNA2,SEMA6B	
Axonal Guidance Signaling	8.61E-01	1.96E-02	NaN	FZD4,GNG11,GNG5,MYL12B,MYL6,PLXNA2,RASD1,SEMA6B,SEMA7A,TUBB2A	
Role of Tissue Factor in Cancer	8.58E-01	2.42E-02	1.342	BCL2L1,CCN2,EGR1,PPP2R2D,RASD1	
PTEN Signaling	8.58E-01	2.65E-02	NaN	BCL2L1,CDKN1A,CDKN1B,RASD1	
Protein folding	8.57E-01	3.06E-02	NaN	GNG11,GNG5,TUBB2A	
Signaling by EGFR	8.53E-01	4E-02	NaN	RPS27A,SPRY1	
RNA Polymerase I Transcription	8.53E-01	4E-02	NaN	POLR2K,POLR2L	
Melanoma Signaling	8.53E-01	4E-02	NaN	CDKN1A,RASD1	
MYC Mediated Apoptosis Signaling	8.53E-01	4E-02	NaN	BCL2L1,FAS	
Assembly of RNA Polymerase II Complex	8.53E-01	4E-02	NaN	POLR2K,POLR2L	
FAT10 Cancer Signaling Pathway	8.53E-01	4E-02	NaN	ACKR3,NFKBIA	
Transcriptional regulation by RUNX1	8.5E-01	2.63E-02	2.000	PSMA6,PSME1,RPS27A,SEM1	
Myelination Signaling Pathway	8.48E-01	2.14E-02	0.378	EIF4EBP1,FZD4,NDRG1,RASD1,SLC2A1,SMAD1,XAF1	
Glycerophospholipid biosynthesis	8.47E-01	3.03E-02	NaN	CHKA,LPIN2,PNPLA2	
HIF1Î± Signaling	8.46E-01	2.39E-02	1.342	CDKN1A,EIF4EBP1,RASD1,RPS6,SLC2A1	
Transcriptional regulation by RUNX2	8.39E-01	3.92E-02	NaN	CDKN1A,SMAD1	
ATM Signaling	8.38E-01	3E-02	NaN	CDKN1A,NFKBIA,PPP2R2D	
Reversible hydration of carbon dioxide	8.33E-01	8.33E-02	NaN	CA5A	
Relaxin Signaling	8.29E-01	2.58E-02	NaN	GNG11,GNG5,NFKBIA,PDE2A	
B-WICH complex positively regulates rRNA expression	8.25E-01	3.85E-02	NaN	POLR2K,POLR2L	
Mouse Embryonic Stem Cell Pluripotency	8.02E-01	2.88E-02	NaN	FZD4,RASD1,SMAD1	
Passive transport by Aquaporins	8.01E-01	7.69E-02	NaN	AQP11	
Dissolution of Fibrin Clot	8.01E-01	7.69E-02	NaN	PLAT	
Azathioprine ADME	8.01E-01	7.69E-02	NaN	XDH	
Guanosine Nucleotides Degradation III	8.01E-01	7.69E-02	NaN	XDH	
Breast Cancer Regulation by Stathmin1	7.9E-01	1.85E-02	1.897	ACKR3,ADGRG1,CCND3,CDKN1B,FZD4,GNG11,GNG5,RASD1,S1PR1,STMN1,TUBB2A	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	7.87E-01	3.64E-02	NaN	FKBP5,TUBB2A	
Signaling by PTK6	7.87E-01	3.64E-02	NaN	CDKN1B,RPS27A	
Lymphotoxin Î² Receptor Signaling	7.87E-01	3.64E-02	NaN	BCL2L1,NFKBIA	
Eicosanoid Signaling	7.82E-01	2.14E-02	2.449	EGR1,GNG11,GNG5,HSPB1,PNPLA2,RASD1	
Serotonin Receptor Signaling	7.76E-01	1.92E-02	1.667	EIF4EBP1,GCH1,GNG11,GNG5,NFKBIA,PNPLA2,RASD1,RHOB,RHOC	
CSDE1 Signaling Pathway	7.75E-01	3.57E-02	NaN	CCND3,RPL9	
DNA Damage/Telomere Stress Induced Senescence	7.75E-01	3.57E-02	NaN	CDKN1A,CDKN1B	
Folate Signaling Pathway	7.75E-01	3.57E-02	NaN	CDKN1A,CDKN1B	
Triacylglycerol Biosynthesis	7.75E-01	3.57E-02	NaN	LPIN2,PLPP6	
Carnitine metabolism	7.71E-01	7.14E-02	NaN	ACACB	
Urate Biosynthesis/Inosine 5'-phosphate Degradation	7.71E-01	7.14E-02	NaN	XDH	
Mevalonate Pathway I	7.71E-01	7.14E-02	NaN	HMGCS2	
Multiple Sclerosis Signaling Pathway	7.7E-01	2.25E-02	0.447	DUSP1,DUSP6,FAS,STAT1,TIPARP	
Signaling by VEGF	7.69E-01	2.78E-02	NaN	CYBA,HSPB1,WASF2	
Telomerase Signaling	7.69E-01	2.78E-02	NaN	CDKN1A,PPP2R2D,RASD1	
CNTF Signaling	7.63E-01	3.51E-02	NaN	RASD1,STAT1	
Î±-Adrenergic Signaling	7.6E-01	2.75E-02	NaN	GNG11,GNG5,RASD1	
CLEAR Signaling Pathway	7.57E-01	2.11E-02	0.447	ATP6V1G1,BNIP3,CASTOR1,DDIT4,PPP2R2D,RASD1	
Signaling by PDGF	7.51E-01	3.45E-02	NaN	PLAT,STAT1	
Iron uptake and transport	7.51E-01	3.45E-02	NaN	ATP6V1G1,RPS27A	
Role of CHK Proteins in Cell Cycle Checkpoint Control	7.51E-01	3.45E-02	NaN	CDKN1A,PPP2R2D	
HMGB1 Signaling	7.48E-01	2.4E-02	NaN	PLAT,RASD1,RHOB,RHOC	
Metabolism of nitric oxide: NOS3 activation and regulation	7.44E-01	6.67E-02	NaN	NOSTRIN	
Circadian Clock	7.4E-01	3.39E-02	NaN	PER1,RPS27A	
Metabolism of water-soluble vitamins and cofactors	7.4E-01	3.39E-02	NaN	ACACB,SLC2A1	
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	7.37E-01	2.68E-02	NaN	POLE4,RPS27A,SEM1	
Androgen Signaling	7.36E-01	2.37E-02	NaN	GNG11,GNG5,POLR2K,POLR2L	
GABA receptor activation	7.29E-01	3.33E-02	NaN	GNG11,GNG5	
GADD45 Signaling	7.29E-01	3.33E-02	NaN	CCND3,CDKN1A	
Antioxidant Action of Vitamin C	7.21E-01	2.63E-02	NaN	NFKBIA,PNPLA2,SLC2A1	
Caspase activation via Death Receptors in the presence of ligand	7.19E-01	6.25E-02	NaN	FAS	
Rap1 signalling	7.19E-01	6.25E-02	NaN	RASGRP2	
Adenosine Nucleotides Degradation II	7.19E-01	6.25E-02	NaN	XDH	
Aldosterone Signaling in Epithelial Cells	7.17E-01	2.33E-02	NaN	DUSP1,HSPB1,HSPE1,SGK1	
CDK5 Signaling	7.14E-01	2.61E-02	NaN	EGR1,PPP2R2D,RASD1	
IL-13 Signaling Pathway	7.06E-01	2.59E-02	NaN	BCL2L1,DUSP1,STAT1	
Bladder Cancer Signaling	7.06E-01	2.59E-02	NaN	CDKN1A,DAPK1,RASD1	
Neuregulin Signaling	6.99E-01	2.56E-02	NaN	CDKN1B,RASD1,RPS6	
PAK Signaling	6.99E-01	2.56E-02	NaN	MYL12B,MYL6,RASD1	
cAMP-mediated signaling	6.97E-01	2.12E-02	0.000	AKAP12,DUSP1,DUSP6,PDE2A,S1PR1	
Transcriptional Regulation by MECP2	6.96E-01	3.17E-02	NaN	FKBP5,SGK1	
Peroxisomal protein import	6.96E-01	3.17E-02	NaN	HMGCL,RPS27A	
Thrombopoietin Signaling	6.96E-01	3.17E-02	NaN	RASD1,STAT1	
ESR-mediated signaling	6.92E-01	2.54E-02	NaN	FKBP5,POLR2K,POLR2L	
Cholecystokinin/Gastrin-mediated Signaling	6.84E-01	2.52E-02	NaN	RASD1,RHOB,RHOC	
Macroautophagy	6.76E-01	3.08E-02	NaN	CHMP4B,GABARAPL2	
Activation of IRF by Cytosolic Pattern Recognition Receptors	6.76E-01	3.08E-02	NaN	NFKBIA,STAT1	
ERB2-ERBB3 Signaling	6.76E-01	3.08E-02	NaN	CDKN1B,RASD1	
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)	6.73E-01	5.56E-02	NaN	HMGCS2	
Glutamate Receptor Signaling	6.66E-01	3.03E-02	NaN	GNG11,GNG5	
Ion channel transport	6.54E-01	2.19E-02	NaN	ATP6V1G1,RPS27A,SGK1,TSC22D3	
Regulation of TP53 Activity through Methylation	6.53E-01	5.26E-02	NaN	RPS27A	
Metabolism of cofactors	6.53E-01	5.26E-02	NaN	GCH1	
FOXO-mediated transcription	6.53E-01	5.26E-02	NaN	TXNIP	
Purine Nucleotides Degradation II (Aerobic)	6.53E-01	5.26E-02	NaN	XDH	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	6.5E-01	2.42E-02	NaN	FZD4,RASD1,SMAD1	
Remodeling of Epithelial Adherens Junctions	6.47E-01	2.94E-02	NaN	CLIP1,TUBB2A	
Glioma Signaling	6.43E-01	2.4E-02	NaN	CCND3,CDKN1A,RASD1	
Role of JAK1 and JAK3 in Î³c Cytokine Signaling	6.38E-01	2.9E-02	NaN	RASD1,STAT1	
MicroRNA Biogenesis Signaling Pathway	6.33E-01	2.14E-02	2.000	POLR2K,POLR2L,RASD1,SMAD1	
Interleukin-12 family signaling	6.33E-01	5E-02	NaN	STAT1	
Inflammasome pathway	6.33E-01	5E-02	NaN	NEK7	
14-3-3-mediated Signaling	6.3E-01	2.36E-02	NaN	CDKN1B,RASD1,TUBB2A	
ISG15 antiviral mechanism	6.2E-01	2.82E-02	NaN	RPS27A,STAT1	
G Beta Gamma Signaling	6.17E-01	2.33E-02	NaN	GNG11,GNG5,RASD1	
IL-6 Signaling	6.17E-01	2.33E-02	NaN	HSPB1,NFKBIA,RASD1	
Ephrin B Signaling	6.11E-01	2.78E-02	NaN	GNG11,GNG5	
HGF Signaling	5.99E-01	2.27E-02	NaN	CDKN1A,MAP3K6,RASD1	
Cellular hexose transport	5.97E-01	4.55E-02	NaN	SLC2A1	
RHO GTPases Activate NADPH Oxidases	5.97E-01	4.55E-02	NaN	CYBA	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	5.97E-01	4.55E-02	NaN	SEC61G	
Chaperone Mediated Autophagy	5.97E-01	4.55E-02	NaN	RPS27A	
ERK5 Signaling	5.94E-01	2.7E-02	NaN	RASD1,SGK1	
P2Y Purigenic Receptor Signaling Pathway	5.93E-01	2.26E-02	NaN	GNG11,GNG5,RASD1	
CCR3 Signaling in Eosinophils	5.87E-01	2.24E-02	NaN	GNG11,GNG5,RASD1	
Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	5.81E-01	4.35E-02	NaN	RSAD2	
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I	5.81E-01	4.35E-02	NaN	CMPK2	
Apelin Cardiac Fibroblast Signaling Pathway	5.81E-01	4.35E-02	NaN	CCN2	
Plasma lipoprotein assembly, remodeling, and clearance	5.78E-01	2.63E-02	NaN	ANGPTL4,RPS27A	
Angiopoietin Signaling	5.78E-01	2.63E-02	NaN	NFKBIA,RASD1	
Hypoxia Signaling in the Cardiovascular System	5.78E-01	2.63E-02	NaN	NFKBIA,UBE2S	
Role of PKR in Interferon Induction and Antiviral Response	5.75E-01	2.21E-02	NaN	FAS,NFKBIA,STAT1	
Oxytocin in Brain Signaling Pathway	5.73E-01	2.01E-02	NaN	GNG11,GNG5,PNPLA2,RASD1	
Interleukin-6 family signaling	5.65E-01	4.17E-02	NaN	STAT1	
Regulation of RUNX1 Expression and Activity	5.65E-01	4.17E-02	NaN	CCND3	
Glycogen metabolism	5.65E-01	4.17E-02	NaN	RPS27A	
Growth hormone receptor signaling	5.65E-01	4.17E-02	NaN	STAT1	
IL-22 Signaling	5.65E-01	4.17E-02	NaN	STAT1	
Tumoricidal Function of Hepatic Natural Killer Cells	5.65E-01	4.17E-02	NaN	FAS	
Human Embryonic Stem Cell Pluripotency	5.64E-01	1.99E-02	2.000	FZD4,KLF2,RASD1,SMAD1	
ILK Signaling	5.64E-01	1.99E-02	NaN	MYL6,PPP2R2D,RHOB,RHOC	
Signaling by NOTCH1	5.62E-01	2.56E-02	NaN	DLL4,RPS27A	
VDR/RXR Activation	5.62E-01	2.56E-02	NaN	CDKN1A,CDKN1B	
NF-ÎºB Activation by Viruses	5.62E-01	2.56E-02	NaN	NFKBIA,RASD1	
Neurotrophin/TRK Signaling	5.62E-01	2.56E-02	NaN	RASD1,SPRY1	
Circadian Rhythm Signaling	5.55E-01	1.87E-02	NaN	EIF4EBP1,GNG11,GNG5,PER1,RASD1	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	5.55E-01	2.53E-02	NaN	NFKBIA,RPS27A	
Signaling by MET	5.55E-01	2.53E-02	NaN	RANBP9,RPS27A	
IL-3 Signaling	5.55E-01	2.53E-02	NaN	RASD1,STAT1	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	5.55E-01	2.53E-02	NaN	NFKBIA,PNPLA2	
PIP3 activates AKT signaling	5.52E-01	2.14E-02	NaN	CDKN1A,CDKN1B,MKRN1	
Insulin Receptor Signaling	5.52E-01	2.14E-02	NaN	EIF4EBP1,RASD1,SGK1	
Cholesterol biosynthesis	5.5E-01	4E-02	NaN	PLPP6	
Insulin processing	5.5E-01	4E-02	NaN	MYRIP	
Role of BRCA1 in DNA Damage Response	5.47E-01	2.5E-02	NaN	CDKN1A,STAT1	
Dopamine Receptor Signaling	5.47E-01	2.5E-02	NaN	GCH1,PPP2R2D	
Cardiac Hypertrophy Signaling (Enhanced)	5.43E-01	1.66E-02	2.121	EIF4EBP1,FZD4,GNG11,GNG5,HSPB1,MAP3K6,PDE2A,RASD1,RPS6	
Activation of anterior HOX genes in hindbrain during early embryogenesis	5.4E-01	2.47E-02	NaN	POLR2K,POLR2L	
Signaling by BMP	5.35E-01	3.85E-02	NaN	SMAD1	
Miscellaneous transport and binding events	5.35E-01	3.85E-02	NaN	LRRC8A	
Interleukin-20 family signaling	5.35E-01	3.85E-02	NaN	STAT1	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	5.35E-01	3.85E-02	NaN	STAT1	
G alpha (s) signalling events	5.26E-01	2.07E-02	NaN	GNG11,GNG5,PDE2A	
Effects of PIP2 hydrolysis	5.22E-01	3.7E-02	NaN	RASGRP2	
Integrin signaling	5.22E-01	3.7E-02	NaN	RASGRP2	
ATF4 activates genes in response to endoplasmic reticulum stress	5.22E-01	3.7E-02	NaN	HERPUD1	
Pyroptosis	5.22E-01	3.7E-02	NaN	CHMP4B	
Cardiomyocyte Differentiation via BMP Receptors	5.22E-01	3.7E-02	NaN	SMAD1	
Glycolysis I	5.22E-01	3.7E-02	NaN	ENO1	
Gluconeogenesis I	5.22E-01	3.7E-02	NaN	ENO1	
Apelin Liver Signaling Pathway	5.22E-01	3.7E-02	NaN	FAS	
Role of MAPK Signaling in the Pathogenesis of Influenza	5.18E-01	2.38E-02	NaN	PNPLA2,RASD1	
Integrin Signaling	5.15E-01	1.89E-02	NaN	MYL12B,RASD1,RHOB,RHOC	
Endocannabinoid Cancer Inhibition Pathway	5.15E-01	2.04E-02	NaN	CCND3,CDKN1A,CDKN1B	
LPS-stimulated MAPK Signaling	5.11E-01	2.35E-02	NaN	NFKBIA,RASD1	
Opioid Signaling Pathway	5.1E-01	1.79E-02	NaN	CDKN1B,GNG11,GNG5,NFKBIA,RASD1	
Cellular Effects of Sildenafil (Viagra)	5E-01	2E-02	NaN	MYL12B,MYL6,PDE2A	
IL-17A Signaling in Fibroblasts	4.98E-01	2.3E-02	NaN	CEBPD,NFKBIA	
HIPPO signaling	4.98E-01	2.3E-02	NaN	PPP2R2D,SMAD1	
PDGF Signaling	4.98E-01	2.3E-02	NaN	RASD1,STAT1	
Processing of Capped Intronless Pre-mRNA	4.96E-01	3.45E-02	NaN	SNRPF	
EGR2 and SOX10-mediated initiation of Schwann cell myelination	4.96E-01	3.45E-02	NaN	PMP22	
Superpathway of Cholesterol Biosynthesis	4.96E-01	3.45E-02	NaN	HMGCS2	
Processing of Capped Intron-Containing Pre-mRNA	4.85E-01	1.74E-02	2.236	POLR2K,POLR2L,SAP18,SNRPF,UBL5	
Nucleotide catabolism	4.84E-01	3.33E-02	NaN	XDH	
Opioid Signalling	4.79E-01	2.22E-02	NaN	GNG11,GNG5	
Acute Myeloid Leukemia Signaling	4.72E-01	2.2E-02	NaN	EIF4EBP1,RASD1	
RANK Signaling in Osteoclasts	4.72E-01	2.2E-02	NaN	MAP3K6,NFKBIA	
BMP signaling pathway	4.72E-01	2.2E-02	NaN	RASD1,SMAD1	
Ovarian Cancer Signaling	4.62E-01	1.9E-02	NaN	FZD4,GJA1,RASD1	
Epithelial Adherens Junction Signaling	4.62E-01	1.9E-02	NaN	MYL12B,PPP2R2D,RASD1	
Toll Like Receptor 3 (TLR3) Cascade	4.61E-01	3.12E-02	NaN	RPS27A	
rRNA processing	4.61E-01	3.12E-02	NaN	PRORP	
TNFR2 Signaling	4.61E-01	3.12E-02	NaN	NFKBIA	
Dopamine Degradation	4.61E-01	3.12E-02	NaN	Sult1a1	
Pyroptosis Signaling Pathway	4.54E-01	2.13E-02	NaN	NEK7,TXNIP	
EPH-Ephrin signaling	4.54E-01	2.13E-02	NaN	MYL12B,MYL6	
Non-Small Cell Lung Cancer Signaling	4.54E-01	2.13E-02	NaN	CCND3,RASD1	
Microautophagy Signaling Pathway	4.53E-01	1.87E-02	NaN	CHMP4B,PSMA6,PSME1	
MAPK targets/ Nuclear events mediated by MAP kinases	4.51E-01	3.03E-02	NaN	DUSP6	
Activation of the pre-replicative complex	4.51E-01	3.03E-02	NaN	POLE4	
HEY1 Signaling Pathway	4.49E-01	1.86E-02	NaN	CDKN1A,DLL4,SMAD1	
Gene Silencing by RNA	4.48E-01	2.11E-02	NaN	POLR2K,POLR2L	
Prolactin Signaling	4.48E-01	2.11E-02	NaN	RASD1,STAT1	
TGF-Î² Signaling	4.43E-01	2.08E-02	NaN	RASD1,SMAD1	
Antimicrobial peptides	4.4E-01	2.94E-02	NaN	ATOX1	
Oncogene Induced Senescence	4.4E-01	2.94E-02	NaN	RPS27A	
Triglyceride metabolism	4.4E-01	2.94E-02	NaN	LPIN2	
4-1BB Signaling in T Lymphocytes	4.4E-01	2.94E-02	NaN	NFKBIA	
HOTAIR Regulatory Pathway	4.4E-01	1.84E-02	NaN	CDKN1A,NFKBIA,RHOC	
Cellular response to heat stress	4.37E-01	2.06E-02	NaN	HSBP1,HSPB1	
Transcriptional Regulatory Network in Embryonic Stem Cells	4.36E-01	1.83E-02	NaN	FZD4,RASD1,SMAD1	
DNA Methylation and Transcriptional Repression Signaling	4.31E-01	2.04E-02	NaN	SAP18,TCF15	
GPVI-mediated activation cascade	4.3E-01	2.86E-02	NaN	RHOB	
Transcriptional Regulation by NPAS4	4.3E-01	2.86E-02	NaN	PLK2	
Coagulation System	4.3E-01	2.86E-02	NaN	PLAT	
IL-9 Signaling	4.3E-01	2.86E-02	NaN	STAT1	
VEGF Signaling	4.26E-01	2.02E-02	NaN	BCL2L1,RASD1	
Apelin Cardiomyocyte Signaling Pathway	4.26E-01	2.02E-02	NaN	MYL12B,MYL6	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	4.24E-01	1.69E-02	0.000	GJA1,MAP3K6,PPP2R2D,RASD1	
Osteoarthritis Pathway	4.24E-01	1.69E-02	0.000	DDIT4,FZD4,SMAD1,TIMP3	
RHO GTPases Activate WASPs and WAVEs	4.21E-01	2.78E-02	NaN	WASF2	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	4.21E-01	2.78E-02	NaN	CDKN1A	
MIF-mediated Glucocorticoid Regulation	4.21E-01	2.78E-02	NaN	NFKBIA	
NRF2-mediated Oxidative Stress Response	4.21E-01	1.69E-02	NaN	FKBP5,HERPUD1,MAFF,RASD1	
Orexin Signaling Pathway	4.17E-01	1.68E-02	2.000	ATP6V1G1,GNG11,GNG5,SMAD1	
Ribonucleotide Reductase Signaling Pathway	4.07E-01	1.75E-02	NaN	CDKN1A,EIF4EBP1,TIPARP	
Potassium Channels	4.05E-01	1.94E-02	NaN	GNG11,GNG5	
Th1 and Th2 Activation Pathway	4.04E-01	1.74E-02	NaN	DLL4,S1PR1,STAT1	
NoRC negatively regulates rRNA expression	4.03E-01	2.63E-02	NaN	SAP18	
Fanconi Anemia Pathway	4.03E-01	2.63E-02	NaN	RPS27A	
Resolution of Abasic Sites (AP sites)	4.03E-01	2.63E-02	NaN	POLE4	
Notch Signaling	4.03E-01	2.63E-02	NaN	DLL4	
Sertoli Cell-Sertoli Cell Junction Signaling	4.01E-01	1.65E-02	2.000	GJA1,MAP3K6,RASD1,TUBB2A	
Actin Cytoskeleton Signaling	3.98E-01	1.64E-02	NaN	MYL12B,MYL6,RASD1,WASF2	
IGF-1 Signaling	3.95E-01	1.9E-02	NaN	CCN2,RASD1	
Inhibition of Matrix Metalloproteases	3.94E-01	2.56E-02	NaN	TIMP3	
CREB Signaling in Neurons	3.92E-01	1.48E-02	2.236	ACKR3,ADGRG1,FZD4,GNG11,GNG5,POLR2K,POLR2L,RASD1,S1PR1	
WNK Renal Signaling Pathway	3.9E-01	1.89E-02	NaN	LRRC8A,SGK1	
Erythropoietin Signaling Pathway	3.88E-01	1.7E-02	NaN	BCL2L1,NFKBIA,RASD1	
Signaling by FGFR3	3.86E-01	2.5E-02	NaN	RPS27A	
Transcriptional Regulation by VENTX	3.86E-01	2.5E-02	NaN	UBE2S	
Pyrimidine Ribonucleotides Interconversion	3.86E-01	2.5E-02	NaN	CMPK2	
Cargo recognition for clathrin-mediated endocytosis	3.85E-01	1.87E-02	NaN	FZD4,RPS27A	
Post-translational protein phosphorylation	3.85E-01	1.87E-02	NaN	PNPLA2,PRSS23	
PPAR Signaling	3.85E-01	1.87E-02	NaN	NFKBIA,RASD1	
PD-1, PD-L1 cancer immunotherapy pathway	3.85E-01	1.87E-02	NaN	BCL2L1,CDKN1B	
ISGylation Signaling Pathway	3.8E-01	1.85E-02	NaN	RPS15,STAT1	
Activation of gene expression by SREBF (SREBP)	3.77E-01	2.44E-02	NaN	ACACB	
Signaling by FGFR4	3.77E-01	2.44E-02	NaN	RPS27A	
Mechanisms of Viral Exit from Host Cells	3.77E-01	2.44E-02	NaN	CHMP4B	
Tumor Microenvironment Pathway	3.77E-01	1.68E-02	NaN	FAS,RASD1,SLC2A1	
Gap Junction Signaling	3.71E-01	1.54E-02	2.236	CDKN1B,GJA1,RASD1,SMAD1,TUBB2A	
Kinetochore Metaphase Signaling Pathway	3.71E-01	1.82E-02	NaN	ARPP19,PTTG1	
April Mediated Signaling	3.7E-01	2.38E-02	NaN	NFKBIA	
Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)	3.7E-01	2.38E-02	NaN	Sult1a1	
Pulmonary Fibrosis Idiopathic Signaling Pathway	3.68E-01	1.53E-02	2.236	CCN2,EGR1,EIF4EBP1,FZD4,RASD1	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	3.67E-01	1.65E-02	NaN	DUSP1,DUSP6,PLPP6	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	3.67E-01	1.65E-02	NaN	DUSP1,DUSP6,PLPP6	
Sleep REM Signaling Pathway	3.66E-01	1.8E-02	NaN	EGR1,Mt1	
Phagosome Formation	3.63E-01	1.44E-02	3.000	ACKR3,ADGRG1,CLIP1,FZD4,MYL12B,MYL6,PNPLA2,RASD1,S1PR1,WASF2	
Signaling by Insulin receptor	3.62E-01	2.33E-02	NaN	ATP6V1G1	
Signaling by SCF-KIT	3.62E-01	2.33E-02	NaN	STAT1	
Assembly and cell surface presentation of NMDA receptors	3.62E-01	2.33E-02	NaN	TUBB2A	
B Cell Activating Factor Signaling	3.62E-01	2.33E-02	NaN	NFKBIA	
Pyrimidine Ribonucleotides De Novo Biosynthesis	3.62E-01	2.33E-02	NaN	CMPK2	
S100 Family Signaling Pathway	3.59E-01	1.42E-02	2.714	ACKR3,ADGRG1,CDKN1A,FZD4,IRAK2,PLAT,S100A13,S100A16,S1PR1,SMAD1,Tpm4	
Sperm Motility	3.58E-01	1.56E-02	NaN	GNG11,GNG5,PDE2A,PNPLA2	
TBC/RABGAPs	3.55E-01	2.27E-02	NaN	GABARAPL2	
MIF Regulation of Innate Immunity	3.55E-01	2.27E-02	NaN	NFKBIA	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	3.5E-01	1.5E-02	NaN	CEBPD,FZD4,IRAK2,NFKBIA,RASD1	
Interleukin-2 family signaling	3.4E-01	2.17E-02	NaN	STAT1	
Role of RIG1-like Receptors in Antiviral Innate Immunity	3.4E-01	2.17E-02	NaN	NFKBIA	
tRNA Splicing	3.4E-01	2.17E-02	NaN	PDE2A	
IL-23 Signaling Pathway	3.4E-01	2.17E-02	NaN	NFKBIA	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	3.36E-01	1.69E-02	NaN	GNG11,GNG5	
nNOS Signaling in Neurons	3.34E-01	2.13E-02	NaN	RASD1	
Regulation of lipid metabolism by PPARalpha	3.32E-01	1.68E-02	NaN	ANGPTL4,HMGCS2	
MSP-RON Signaling in Macrophages Pathway	3.32E-01	1.68E-02	NaN	RASD1,STAT1	
Leukocyte Extravasation Signaling	3.3E-01	1.55E-02	NaN	CYBA,MYL6,TIMP3	
3-phosphoinositide Degradation	3.3E-01	1.55E-02	NaN	DUSP1,DUSP6,PLPP6	
NGF Signaling	3.28E-01	1.67E-02	NaN	MAP3K6,RASD1	
Retinol Biosynthesis	3.27E-01	2.08E-02	NaN	PNPLA2	
PPARÎ±/RXRÎ± Activation	3.27E-01	1.55E-02	NaN	ADIPOR2,NFKBIA,RASD1	
Renin-Angiotensin Signaling	3.24E-01	1.65E-02	NaN	RASD1,STAT1	
Regulation of the Epithelial-Mesenchymal Transition Pathway	3.24E-01	1.54E-02	NaN	EGR1,FZD4,RASD1	
PFKFB4 Signaling Pathway	3.21E-01	2.04E-02	NaN	XDH	
Th1 Pathway	3.2E-01	1.64E-02	NaN	DLL4,STAT1	
Synaptic Long Term Depression	3.15E-01	1.52E-02	NaN	PNPLA2,PPP2R2D,RASD1	
D-myo-inositol-5-phosphate Metabolism	3.15E-01	1.52E-02	NaN	DUSP1,DUSP6,PLPP6	
Signaling by ERBB2	3.15E-01	2E-02	NaN	RPS27A	
Signaling by FGFR1	3.15E-01	2E-02	NaN	RPS27A	
Dermatan Sulfate Biosynthesis (Late Stages)	3.15E-01	2E-02	NaN	CHST2	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	3.12E-01	1.61E-02	NaN	PNPLA2,PRSS23	
Insulin Secretion Signaling Pathway	3.1E-01	1.45E-02	1.000	EIF4EBP1,SEC61G,SLC2A1,STAT1	
L1CAM interactions	3.09E-01	1.6E-02	NaN	RANBP9,TUBB2A	
Transcriptional regulation of granulopoiesis	3.09E-01	1.96E-02	NaN	CDKN1A	
TNFR1 Signaling	3.09E-01	1.96E-02	NaN	NFKBIA	
UVC-Induced MAPK Signaling	3.09E-01	1.96E-02	NaN	RASD1	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	3.09E-01	1.96E-02	NaN	CDKN1A	
GÎ±s Signaling	3.05E-01	1.59E-02	NaN	GNG11,GNG5	
Ephrin Receptor Signaling	3.03E-01	1.49E-02	NaN	GNG11,GNG5,RASD1	
Apoptotic execution phase	3.03E-01	1.92E-02	NaN	HMGB2	
UVB-Induced MAPK Signaling	3.03E-01	1.92E-02	NaN	EIF4EBP1	
ROBO SLIT Signaling Pathway	3.01E-01	1.57E-02	NaN	CDKN1A,MYL12B	
Mitotic Prometaphase	3E-01	1.48E-02	NaN	CLIP1,NEK7,TUBB2A	
Signaling by TGF-beta Receptor Complex	2.97E-01	1.89E-02	NaN	RPS27A	
Chondroitin Sulfate Biosynthesis (Late Stages)	2.97E-01	1.89E-02	NaN	CHST2	
Clathrin-mediated endocytosis	2.91E-01	1.54E-02	NaN	FZD4,RPS27A	
3-phosphoinositide Biosynthesis	2.86E-01	1.44E-02	NaN	DUSP1,DUSP6,PLPP6	
Intrinsic Pathway for Apoptosis	2.86E-01	1.82E-02	NaN	BCL2L1	
Metabolism of non-coding RNA	2.86E-01	1.82E-02	NaN	SNRPF	
Interleukin-3, Interleukin-5 and GM-CSF signaling	2.86E-01	1.82E-02	NaN	RPS27A	
E3 ubiquitin ligases ubiquitinate target proteins	2.86E-01	1.82E-02	NaN	RPS27A	
Response to elevated platelet cytosolic Ca2+	2.84E-01	1.52E-02	NaN	SELENOP,TIMP3	
EGF Signaling	2.81E-01	1.79E-02	NaN	STAT1	
Atherosclerosis Signaling	2.8E-01	1.5E-02	NaN	PNPLA2,TNFRSF12A	
TNF signaling	2.75E-01	1.75E-02	NaN	RPS27A	
Role of IL-17A in Arthritis	2.75E-01	1.75E-02	NaN	NFKBIA	
STAT3 Pathway	2.74E-01	1.48E-02	NaN	CDKN1A,RASD1	
Triacylglycerol Degradation	2.7E-01	1.72E-02	NaN	PNPLA2	
Cancer Drug Resistance by Drug Efflux	2.7E-01	1.72E-02	NaN	RASD1	
RAC Signaling	2.67E-01	1.46E-02	NaN	MCF2L,RASD1	
Xenobiotic Metabolism Signaling	2.65E-01	1.36E-02	NaN	CHST2,MAP3K6,PPP2R2D,RASD1	
DNA Double Strand Break Response	2.65E-01	1.69E-02	NaN	RPS27A	
Iron homeostasis signaling pathway	2.64E-01	1.45E-02	NaN	ATP6V1G1,SMAD1	
GABAergic Receptor Signaling Pathway (Enhanced)	2.61E-01	1.44E-02	NaN	GNG11,GNG5	
Visual phototransduction	2.61E-01	1.67E-02	NaN	STRA6	
Endometrial Cancer Signaling	2.61E-01	1.67E-02	NaN	RASD1	
Retinoic acid Mediated Apoptosis Signaling	2.61E-01	1.67E-02	NaN	TIPARP	
PCP (Planar Cell Polarity) Pathway	2.61E-01	1.67E-02	NaN	FZD4	
MSP-RON Signaling in Cancer Cells Pathway	2.58E-01	1.43E-02	NaN	NFKBIA,RASD1	
Kinesins	2.56E-01	1.64E-02	NaN	TUBB2A	
Chondroitin Sulfate Biosynthesis	2.56E-01	1.64E-02	NaN	CHST2	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	2.55E-01	1.42E-02	NaN	CEBPD,EGR1	
UFMylation Signaling Pathway	2.51E-01	1.61E-02	NaN	RPL26	
IL-2 Signaling	2.51E-01	1.61E-02	NaN	RASD1	
Xenobiotic Metabolism General Signaling Pathway	2.49E-01	1.4E-02	NaN	MAP3K6,RASD1	
Hepatic Cholestasis	2.48E-01	1.35E-02	NaN	IRAK2,NFKBIA,TNFRSF12A	
Dermatan Sulfate Biosynthesis	2.47E-01	1.59E-02	NaN	CHST2	
Role of NFAT in Cardiac Hypertrophy	2.46E-01	1.34E-02	NaN	GNG11,GNG5,RASD1	
Melatonin Degradation I	2.43E-01	1.56E-02	NaN	Sult1a1	
NAFLD Signaling Pathway	2.42E-01	1.33E-02	NaN	ACACB,PNPLA2,PPP2R2D	
PXR/RXR Activation	2.38E-01	1.54E-02	NaN	HMGCS2	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	2.34E-01	1.52E-02	NaN	NFKBIA	
WNT/Ca+ pathway	2.34E-01	1.52E-02	NaN	FZD4	
WNT/SHH Axonal Guidance Signaling Pathway	2.32E-01	1.34E-02	NaN	FZD4,PLXNA2	
Endocannabinoid Neuronal Synapse Pathway	2.32E-01	1.34E-02	NaN	GNG11,GNG5	
CD40 Signaling	2.3E-01	1.49E-02	NaN	NFKBIA	
IL-17A Signaling in Airway Cells	2.3E-01	1.49E-02	NaN	NFKBIA	
Dilated Cardiomyopathy Signaling Pathway	2.3E-01	1.33E-02	NaN	MYL6,PDE2A	
ERBB4 Signaling	2.26E-01	1.47E-02	NaN	RASD1	
Agrin Interactions at Neuromuscular Junction	2.22E-01	1.45E-02	NaN	RASD1	
Phospholipases	2.22E-01	1.45E-02	NaN	PNPLA2	
Superpathway of Melatonin Degradation	2.22E-01	1.45E-02	NaN	Sult1a1	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	2.15E-01	1.41E-02	NaN	TUBB2A	
Growth Hormone Signaling	2.15E-01	1.41E-02	NaN	STAT1	
Basal Cell Carcinoma Signaling	2.11E-01	1.39E-02	NaN	FZD4	
Amyloid fiber formation	2.07E-01	1.37E-02	NaN	RPS27A	
Serotonin Degradation	2.07E-01	1.37E-02	NaN	Sult1a1	
trans-Golgi Network Vesicle Budding	2.04E-01	1.35E-02	NaN	SORT1	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	1.89E-01	1.32E-02	NaN	FZD4,NFKBIA,SMAD1	
GDNF Family Ligand-Receptor Interactions	1.33E-01	1.32E-02	NaN	RASD1	
Macropinocytosis Signaling	1.33E-01	1.32E-02	NaN	RASD1	
Neurovascular Coupling Signaling Pathway	-0E00	8.62E-03	NaN	GJA1,PNPLA2	
Wound Healing Signaling Pathway	-0E00	1.19E-02	NaN	NFKBIA,RASD1,STAT1	
SNARE Signaling Pathway	-0E00	7.35E-03	NaN	MYL6	
CDX Gastrointestinal Cancer Signaling Pathway	-0E00	4.95E-03	NaN	FZD4	
Immunogenic Cell Death Signaling Pathway	-0E00	1.11E-02	NaN	DAPK1	
Macrophage Classical Activation Signaling Pathway	-0E00	1.06E-02	NaN	NFKBIA,STAT1	
Pathogen Induced Cytokine Storm Signaling Pathway	-0E00	5.39E-03	NaN	SLC2A1,STAT1	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	-0E00	1.23E-02	NaN	FZD4,SMAD1,STAT1	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	-0E00	1.3E-02	2.000	NFKBIA,RASD1,RHOB,RHOC	
Natural Killer Cell Signaling	-0E00	1.01E-02	NaN	MAP3K6,RASD1	
Synaptic Long Term Potentiation	-0E00	7.58E-03	NaN	RASD1	
Amyotrophic Lateral Sclerosis Signaling	-0E00	8.62E-03	NaN	BCL2L1	
Fc Epsilon RI Signaling	-0E00	8.47E-03	NaN	RASD1	
Chaperone Mediated Autophagy Signaling Pathway	-0E00	7.87E-03	-1.342	ATP6V1G1,NFKBIA,PSMA6,PSME1,TPT1	
IL-33 Signaling Pathway	-0E00	1.08E-02	NaN	BCL2L1,NFKBIA	
NOD1/2 Signaling Pathway	-0E00	5.29E-03	NaN	NFKBIA	
DHCR24 Signaling Pathway	-0E00	7.3E-03	NaN	RASD1	
Adrenergic Receptor Signaling Pathway (Enhanced)	-0E00	5E-03	NaN	ATP6V1G1	
Glutaminergic Receptor Signaling Pathway (Enhanced)	-0E00	3.08E-03	NaN	PNPLA2	
NFKBIE Signaling Pathway	-0E00	2.23E-03	NaN	NFKBIA	
LPS/IL-1 Mediated Inhibition of RXR Function	-0E00	7.78E-03	NaN	CHST2,HMGCS2	
G alpha (i) signalling events	-0E00	1.16E-02	NaN	ACKR3,GNG11,GNG5	
Glycosaminoglycan metabolism	-0E00	1.25E-02	NaN	B4GALT4	
Signaling by NTRK1 (TRKA)	-0E00	1.23E-02	NaN	DUSP6	
Fcgamma receptor (FCGR) dependent phagocytosis	-0E00	6.37E-03	NaN	WASF2	
MHC class II antigen presentation	-0E00	7.94E-03	NaN	TUBB2A	
Oxidative Stress Induced Senescence	-0E00	1.16E-02	NaN	RPS27A	
Class A/1 (Rhodopsin-like receptors)	-0E00	6.31E-03	NaN	ACKR3,S1PR1	
G alpha (q) signalling events	-0E00	1.15E-02	NaN	GNG11,GNG5	
Transport of bile salts and organic acids, metal ions and amine compounds	-0E00	1.2E-02	NaN	SLC30A1	
Sphingolipid metabolism	-0E00	1.15E-02	NaN	GLTP	
Activation of NMDA receptors and postsynaptic events	-0E00	1.19E-02	NaN	TUBB2A	
O-linked glycosylation	-0E00	9.01E-03	NaN	GALNT15	
Mitochondrial translation	-0E00	1.04E-02	NaN	MRPS21	
Cardiac conduction	-0E00	7.69E-03	NaN	HIPK1	
Cilium Assembly	-0E00	4.9E-03	NaN	TUBB2A	
Neutrophil degranulation	-0E00	8.4E-03	2.000	CSTB,CYBA,NDUFC2,PGLYRP1	
COPI-mediated anterograde transport	-0E00	9.8E-03	NaN	TUBB2A	
Intra-Golgi and retrograde Golgi-to-ER traffic	-0E00	9.85E-03	NaN	NAA38,TUBB2A	
Interferon gamma signaling	-0E00	1.06E-02	NaN	STAT1	
Factors involved in megakaryocyte development and platelet production	-0E00	1.1E-02	NaN	MAFF	
Acute Phase Response Signaling	-0E00	1.08E-02	NaN	NFKBIA,RASD1	
Autism Signaling Pathway	-0E00	1.3E-02	1.000	EIF4EBP1,FZD4,RASD1,RPS6	
Pancreatic Secretion Signaling Pathway	-0E00	8.1E-03	NaN	CA5A,EIF4EBP1	
Protein Sorting Signaling Pathway	-0E00	5.62E-03	NaN	SORT1	
FXR/RXR Activation	-0E00	1.07E-02	NaN	Mt1,TXNIP	
BBSome Signaling Pathway	-0E00	8.18E-03	2.000	ACKR3,ADGRG1,FZD4,S1PR1	
IL-27 Signaling Pathway	-0E00	7.81E-03	NaN	STAT1	
Sleep NREM Signaling Pathway	-0E00	8.7E-03	NaN	RASD1	
Tight Junction Signaling	-0E00	1.11E-02	NaN	MYL6,PPP2R2D	
Clathrin-mediated Endocytosis Signaling	-0E00	9.62E-03	NaN	RPS27A,Ubb	
IL-12 Signaling and Production in Macrophages	-0E00	4.26E-03	NaN	STAT1	
Role of NFAT in Regulation of the Immune Response	-0E00	3.87E-03	NaN	GNG11,GNG5,NFKBIA,RASD1	
FcÎ³RIIB Signaling in B Lymphocytes	-0E00	1.88E-03	NaN	RASD1	
CCR5 Signaling in Macrophages	-0E00	6.01E-03	NaN	FAS,GNG11,GNG5	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00	2.35E-03	NaN	FAS	
IL-17 Signaling	-0E00	5.35E-03	NaN	RASD1	
CTLA4 Signaling in Cytotoxic T Lymphocytes	-0E00	4.93E-03	NaN	BCL2L1,PPP2R2D,RASD1	
IL-15 Production	-0E00	8.13E-03	NaN	STAT1	
T Helper Cell Differentiation	-0E00	2.12E-03	NaN	STAT1	
CD28 Signaling in T Helper Cells	-0E00	1.93E-03	NaN	NFKBIA	
IL-15 Signaling	-0E00	3.8E-03	NaN	BCL2L1,RASD1	
Virus Entry via Endocytic Pathways	-0E00	8.47E-03	NaN	RASD1	
Dendritic Cell Maturation	-0E00	3.36E-03	NaN	NFKBIA,STAT1	
Endothelin-1 Signaling	-0E00	1.03E-02	NaN	PNPLA2,RASD1	
Factors Promoting Cardiogenesis in Vertebrates	-0E00	1.31E-02	NaN	FZD4,SMAD1	
Docosahexaenoic Acid (DHA) Signaling	-0E00	1.2E-02	NaN	BCL2L1,FAS,PNPLA2	
ICOS-ICOSL Signaling in T Helper Cells	-0E00	1.97E-03	NaN	NFKBIA	
Maturity Onset Diabetes of Young (MODY) Signaling	-0E00	1.27E-02	NaN	UCP2	
Melanocyte Development and Pigmentation Signaling	-0E00	1.02E-02	NaN	RASD1	
Type I Diabetes Mellitus Signaling	-0E00	5.89E-03	NaN	FAS,NFKBIA,STAT1	
Allograft Rejection Signaling	-0E00	2.05E-03	NaN	FAS	
Autoimmune Thyroid Disease Signaling	-0E00	2.18E-03	NaN	FAS	
Thyroid Cancer Signaling	-0E00	1.27E-02	NaN	RASD1	
Graft-versus-Host Disease Signaling	-0E00	2.24E-03	NaN	FAS	
Type II Diabetes Mellitus Signaling	-0E00	1.31E-02	NaN	ADIPOR2,NFKBIA	
p70S6K Signaling	-0E00	5.18E-03	NaN	PPP2R2D,RASD1,RPS6	
G Protein Signaling Mediated by Tubby	-0E00	4.27E-03	NaN	GNG11,GNG5	
Crosstalk between Dendritic Cells and Natural Killer Cells	-0E00	1.1E-02	NaN	FAS	
Systemic Lupus Erythematosus Signaling	-0E00	3.75E-03	NaN	RASD1,Snrpe,SNRPF,Snrpg	
CDC42 Signaling	-0E00	5.21E-03	NaN	CLIP1,MYL12B,MYL6	
FAK Signaling	-0E00	4.8E-03	2.236	ACKR3,ADGRG1,FZD4,RASD1,S1PR1	
Phospholipase C Signaling	-0E00	6.25E-03	2.449	GNG11,GNG5,MYL12B,MYL6,RASD1,RHOB,RHOC	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00	1.07E-03	NaN	FAS	
Estrogen-Dependent Breast Cancer Signaling	-0E00	1.22E-02	NaN	RASD1	
Neuroprotective Role of THOP1 in Alzheimer's Disease	-0E00	8.2E-03	NaN	PRSS23	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	-0E00	4.33E-03	NaN	NFKBIA,RASD1	
Role of WNT/GSK-3Î² Signaling in the Pathogenesis of Influenza	-0E00	1.28E-02	NaN	FZD4	
PKCÎ¸ Signaling in T Lymphocytes	-0E00	5.38E-03	NaN	MAP3K6,NFKBIA,RASD1	
Antiproliferative Role of TOB in T Cell Signaling	-0E00	2.35E-03	NaN	CDKN1B	
OX40 Signaling Pathway	-0E00	4.18E-03	NaN	BCL2L1,NFKBIA	
PI3K Signaling in B Lymphocytes	-0E00	3.4E-03	NaN	NFKBIA,RASD1	
Dopamine-DARPP32 Feedback in cAMP Signaling	-0E00	5.38E-03	NaN	PPP2R2D	
Paxillin Signaling	-0E00	9.35E-03	NaN	RASD1	
eNOS Signaling	-0E00	1.28E-02	NaN	AQP11,NOSTRIN	
VEGF Family Ligand-Receptor Interactions	-0E00	1.19E-02	NaN	RASD1	
ERBB Signaling	-0E00	1.08E-02	NaN	RASD1	
Heparan Sulfate Biosynthesis	-0E00	1.11E-02	NaN	CHST2	
Heparan Sulfate Biosynthesis (Late Stages)	-0E00	1.2E-02	NaN	CHST2	
Superpathway of Inositol Phosphate Compounds	-0E00	1.27E-02	NaN	DUSP1,DUSP6,PLPP6	
Agranulocyte Adhesion and Diapedesis	-0E00	9.52E-03	NaN	ACKR3,MYL6	
Granulocyte Adhesion and Diapedesis	-0E00	5.29E-03	NaN	ACKR3	
TEC Kinase Signaling	-0E00	1.04E-02	2.000	FAS,GNG11,GNG5,RHOB,RHOC,STAT1	
Unfolded protein response	-0E00	1.11E-02	NaN	CEBPD	
SAPK/JNK Signaling	-0E00	5.98E-03	NaN	GNG11,GNG5,RASD1	
Nitric Oxide Signaling in the Cardiovascular System	-0E00	8.33E-03	NaN	PDE2A	
IL-4 Signaling	-0E00	8.67E-03	0.447	BCL2L1,EIF4EBP1,FAS,RASD1,TIMP3	
B Cell Receptor Signaling	-0E00	7.89E-03	2.000	BCL2L1,EGR1,MAP3K6,NFKBIA,RASD1	
Chemokine Signaling	-0E00	1.23E-02	NaN	RASD1	
NF-ÎºB Signaling	-0E00	3.5E-03	NaN	NFKBIA,RASD1	
T Cell Receptor Signaling	-0E00	6.49E-03	-1.000	CDKN1B,DUSP6,NFKBIA,RASD1	
Gustation Pathway	-0E00	4.95E-03	NaN	LRRC8A	
Phagosome Maturation	-0E00	1.22E-02	NaN	ATP6V1G1,TUBB2A	
Th2 Pathway	-0E00	7.3E-03	NaN	S1PR1	
GP6 Signaling Pathway	-0E00	7.87E-03	NaN	RASGRP2	
Neuroinflammation Signaling Pathway	-0E00	9.46E-03	NaN	FAS,IRAK2,STAT1	
Adrenomedullin signaling pathway	-0E00	5.03E-03	NaN	RASD1	
Th17 Activation Pathway	-0E00	2.07E-03	NaN	IRAK2	
T Cell Exhaustion Signaling Pathway	-0E00	5.29E-03	NaN	PPP2R2D,RASD1,STAT1	
Synaptogenesis Signaling Pathway	-0E00	9.52E-03	NaN	EIF4EBP1,RASD1,RASGRP2	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	-0E00	7.78E-03	1.000	FAS,PPP2R2D,RASD1,RHOB,RHOC	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	-0E00	8.3E-03	2.449	BCL2L1,CCND3,IFIT3,RASD1,RASGRP2,STAT1	
Xenobiotic Metabolism CAR Signaling Pathway	-0E00	1.03E-02	NaN	CHST2,PPP2R2D	
Xenobiotic Metabolism PXR Signaling Pathway	-0E00	5.13E-03	NaN	CHST2	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	-0E00	1.04E-02	NaN	EGR1,RASD1	
Regulation of the Epithelial Mesenchymal Transition in Development Pathway	-0E00	1.15E-02	NaN	FZD4	
Calcium Signaling	-0E00	9.09E-03	NaN	MYL6,Tpm4	
